BAT
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Botulism
Conditions
Botulism
Trial Timeline
Oct 1, 2014 → Jul 1, 2017
NCT ID
NCT02055183About BAT
BAT is a pre-clinical stage product being developed by Emergent BioSolutions for Botulism. The current trial status is completed. This product is registered under clinical trial identifier NCT02055183. Target conditions include Botulism.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02055183 | Pre-clinical | Completed |
Competing Products
1 competing product in Botulism
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Blood sample collection | Emergent BioSolutions | Approved | 77 |